7-10982666-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001007157.2(PHF14):āc.407A>Cā(p.Glu136Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000184 in 1,578,194 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001007157.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF14 | NM_001007157.2 | c.407A>C | p.Glu136Ala | missense_variant | 3/18 | ENST00000634607.2 | NP_001007158.1 | |
PHF14 | NM_014660.4 | c.407A>C | p.Glu136Ala | missense_variant | 3/17 | NP_055475.2 | ||
PHF14 | NR_033435.2 | n.564+7721A>C | intron_variant | |||||
PHF14 | NR_033436.2 | n.564+7721A>C | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152178Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000154 AC: 3AN: 195032Hom.: 0 AF XY: 0.00000958 AC XY: 1AN XY: 104344
GnomAD4 exome AF: 0.0000189 AC: 27AN: 1426016Hom.: 1 Cov.: 35 AF XY: 0.0000269 AC XY: 19AN XY: 706048
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152178Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | The c.407A>C (p.E136A) alteration is located in exon 3 (coding exon 3) of the PHF14 gene. This alteration results from a A to C substitution at nucleotide position 407, causing the glutamic acid (E) at amino acid position 136 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at